SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-009059
Filing Date
2019-08-08
Accepted
2019-08-08 16:11:25
Documents
42
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT mnpr_form10q.htm 10-Q 788788
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-1ceov2.htm EX-31 11821
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit_31-2cfov2.htm EX-31 11867
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit_32-1v2.htm EX-32 8606
  Complete submission text file 0001654954-19-009059.txt   2217769

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mono-20190630.xml EX-101.INS 301483
6 XBRL TAXONOMY EXTENSION SCHEMA mono-20190630.xsd EX-101.SCH 18141
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20190630_cal.xml EX-101.CAL 26309
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20190630_def.xml EX-101.DEF 42777
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20190630_lab.xml EX-101.LAB 138578
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20190630_pre.xml EX-101.PRE 110546
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-55866 | Film No.: 191009613
SIC: 2834 Pharmaceutical Preparations